Cargando...

RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION

Aim. To assess effectiveness and safety of the hospital use of recombinant non-immunogenic staphylokinase in patients with acute  ST-elevated myocardial infarction (STEMI).Material and methods. Recombinant non-immunogenic staphylokinase was administered during in-hospital stage of treatment of 93 pa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Autor Principal: V. B. Kostogryz
Formato: Artigo
Idioma:Inglês
Publicado: Stolichnaya Izdatelskaya Kompaniya 2017-03-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Assuntos:
Acceso en liña:https://www.rpcardio.com/jour/article/view/1416
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!